Gavin L A
West J Med. 1989 Nov;151(5):525-9.
Patients with diabetes mellitus are subjected to major operations more frequently than those without diabetes. Although many of these operations are done on an elective basis, the perioperative control of blood glucose levels--ranging from 6.7 to 13.3 mmol per liter (120 to 240 mg per dl)--remains a therapeutic challenge. In planning the management, the type of diabetes, current treatment, the degree of recent control, the presence of complications, and the type of surgical procedure must all be considered. All insulin-dependent patients and many non-insulin-dependent ones need insulin therapy perioperatively. The variable stress associated with major procedures such as coronary artery bypass and kidney transplantation makes a flexible insulin regimen desirable, which can be provided using a continuous insulin (regular) infusion system and frequent bedside blood glucose monitoring. Implementing such a regimen facilitates rapid control before an operation and a quick response to blood glucose changes during the procedure and provides a convenient and predictable method of control during the postoperative period.
糖尿病患者比非糖尿病患者更频繁地接受大手术。尽管许多此类手术是择期进行的,但将血糖水平控制在6.7至13.3毫摩尔/升(120至240毫克/分升)的围手术期血糖控制仍然是一项治疗挑战。在制定治疗方案时,必须考虑糖尿病的类型、当前治疗、近期控制程度、并发症的存在以及手术类型。所有胰岛素依赖型患者和许多非胰岛素依赖型患者在围手术期都需要胰岛素治疗。与冠状动脉搭桥和肾移植等大手术相关的可变应激使得采用灵活的胰岛素治疗方案成为理想选择,这可以通过连续胰岛素(常规)输注系统和频繁的床边血糖监测来实现。实施这样的治疗方案有助于在手术前快速控制血糖,并在手术过程中对血糖变化做出快速反应,同时在术后提供一种方便且可预测的控制方法。